FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

If you use a continuous glucose monitoring (CGM) system, you usually have to remove the sensor before any imaging tests like ...

Continuous glucose monitors (CGMs) are monitoring devices people with diabetes use. They apply them directly to the skin and ...

The Kilkenny, Ireland facility will focus on the global manufacturing of sensors for Abbott’s CGM diabetes devices.

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.

Opens in a new tab or window Abbott's FreeStyle Libre 2 and 3 are the first and only patient-applied continuous glucose monitoring (CGM) systems to be approved for use during medical imaging ...

--(BUSINESS WIRE)--Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce a ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide a continuous, automatic stream of data from patients using FreeStyle Libre CGM to ...